Concepedia

George M. Gill

GM

Statistics

Publications

14

Citations

888

H-Index

12

Active since

1979

Affiliations

Oncolytics Biotech (Canada)(Current)

The Ohio State University

Georgetown University

Georgetown University Medical Center

Cedars-Sinai Medical Center

George M. Gill is an author at Oncolytics Biotech (Canada) specializing in medicine, oncology, and pharmacology.

Publications per year

1979–2015

14

Publications

14

Phase 1 Clinical Trial of Intratumoral Reovirus Infusion for the Treatment of Recurrent Malignant Gliomas in Adults

Kimberly Kicielinski, E. Antonio Chiocca, John S. Yu et al. · Molecular Therapy · 2014 · 162 citations · Full text

Medicine, Neurology, Oncology +17

Intravenous administration of Reolysin®, a live replication competent RNA virus is safe in patients with advanced solid tumors

R. Gollamudi, Mohammad H. Ghalib, Kavita Desai et al. · Investigational New Drugs · 2009 · 150 citations · Full text

Life Sciences, Oncology, Molecular Oncology +11

A Phase I Study of the Combination of Intravenous Reovirus Type 3 Dearing and Gemcitabine in Patients with Advanced Cancer

Martijn P. Lolkema, Hendrik‐Tobias Arkenau, Kevin J. Harrington et al. · Clinical Cancer Research · 2010 · 122 citations

Medicine, Oncology, Pharmacology +16

A Phase I study of LGD1069 in adults with advanced cancer.

Naiyer A. Rizvi, John L. Marshall, William Dahut et al. · PubMed · 1999 · 104 citations

Medicine, Oncology, Pharmacology +17

Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with <scp>K</scp>RAS‐activated tumors

Miguel A. Villalona‐Calero, Elaine T. Lam, Gregory A. Otterson et al. · Cancer · 2015 · 70 citations · Full text

Medicine, Oncology, Pharmacology +15

1–5 of 14